SRTS
Sensus Healthcare·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 2
Ample Liquidity
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SRTS
Sensus Healthcare, Inc.
A medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions
Healthcare Equipment and Supplies
05/07/2010
07/26/2016
NASDAQ Stock Exchange
54
12-31
Common stock
851 Broken Sound Pkwy., NW #215, Boca Raton, Florida 33487
--
Sensus Healthcare, Inc., a Delaware limited liability company, was formed on May 7, 2010. The company is a medical device company dedicated to providing highly effective, non-invasive, cost-effective treatments for both neoplastic and non-neoplastic skin conditions. Using a proprietary low-energy X-ray technology known as superficial radiation therapy (" SRT "), which is based on more than ten years of dedicated research and development, the company has successfully incorporated SRT into a portfolio of therapeutic devices: SRT-100TM, SRT-100 + TM and SRT-100 VisionTM. To date, SRT technology has been used to effectively and safely treat both neoplastic and non-neoplastic skin diseases in hundreds of thousands of patients worldwide.
Earnings Call
Q1/2025
Estimate EPS0.02
Actual EPS-0.16
Estimate Revenue7.23M
Actual Revenue8.34M
Sensus Healthcare's Q1 2025: Key Contradictions in Revenue Contributions, Installations, and Market Strategy
May 21,2025 02:04
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SRTS has released its 2025 Q3 earnings. EPS was reported at -0.06, versus the expected -0.11, beating expectations. The chart below visualizes how SRTS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SRTS has released its 2025 Q3 earnings report, with revenue of 6.88M, reflecting a YoY change of -22.12%, and net profit of -943.00K, showing a YoY change of -177.61%. The Sankey diagram below clearly presents SRTS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
